Aimed Alliance Submits Comments to FDA / FTC on Competitive Marketplace for Biosimilars
On March 9, 2020, the U.S. Food and Drug Administration (FDA) and the Federal Trade…
Browsing: FDA
FDA and FTC Warn 7 Companies Against Marketing Unapproved Coronavirus Therapies
On March 6, 2020, the U.S. Food and Drug Administration (FDA) and the U.S. Federal…
FDA Issues Report to Congress on CBD Products
On March 5, 2020, the U.S. Food and Drug Administration (FDA) issued a report to…
Congressional Cannabis Hearing Highlights a Need for Cautious Reform
On January 15, 2020, the House Energy and Commerce Health Subcommittee held a hearing on…
FDA Indicates that CBD Is Not Yet Generally Recognized as Safe
Stakeholders and advocates have been waiting for the U.S. Food and Drug Administration (FDA) to…
Aimed Alliances Summits Comment to FDA in Support of Approval for Cardiovascular Treatment
On October 30, 2019, Aimed Alliance summitted a comment to the U.S. Food and Drug…
Congressional Leaders Pressure FDA to Act Quickly on CBD Regulation
Earlier this month, Senate Majority Leader Mitch McConnell moved to include report language in the…
FDA Issues Warning About Harmful Health Product
Earlier this month, the U.S. Food and Drug Administration (FDA) issued a consumer warning about…
Trump Administration Releases Plan to Allow Prescription Drug Importation
On July 31, 2019, the Trump Administration issued a press release that outlined a forthcoming…
FDA Announces Forthcoming Report on Regulatory Framework for CBD Products
On July 23, 2019, the FDA announced that it expects to issue an update on…